Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Microbes Environ ; 39(2)2024.
Article in English | MEDLINE | ID: mdl-38897967

ABSTRACT

To investigate mycobacterial cases of farmed yellowtail fish in coastal areas of western Japan (Kagoshima, Kyushu), where aquaculture fisheries are active, Mycobacterium pseudoshottsii, the causative agent, was isolated from six neighboring fishing ports in 2012 and 2013. A phylogenetic ana-lysis revealed that the strains isolated from one fishing port were closely related to those isolated from other regions of Japan, suggesting the nationwide spread of a single strain. However, strains from Japan were phylogenetically distinct from those from the Mediterranean and the United States; therefore, worldwide transmission was not observed based on the limited data obtained on the strains exami-ned in this study. The present results demonstrate that a bacterial genomic ana-lysis of infected cases, a mole-cular epidemiology strategy for public health, provides useful data for estimating the prevalence and transmission pathways of M. pseudoshottsii in farmed fish. A bacterial genome ana-lysis of strains, such as that performed herein, may play an important role in monitoring the prevalence of this pathogen in fish farms and possible epidemics in the future as a result of international traffic, logistics, and trade in fisheries.


Subject(s)
Aquaculture , Fish Diseases , Genome, Bacterial , Mycobacterium Infections , Phylogeny , Japan/epidemiology , Animals , Fish Diseases/microbiology , Fish Diseases/epidemiology , Mycobacterium Infections/veterinary , Mycobacterium Infections/microbiology , Mycobacterium Infections/epidemiology , Genome, Bacterial/genetics , Mycobacterium/genetics , Mycobacterium/classification , Mycobacterium/isolation & purification , Fishes/microbiology , Fisheries , Genomics , Molecular Epidemiology , Prevalence
2.
J Infect Chemother ; 2024 Jun 11.
Article in English | MEDLINE | ID: mdl-38871252

ABSTRACT

Although clofazimine is currently one of the standard regimens for Mycobacterium abscessus, it frequently causes skin discoloration, posing esthetic concerns for patients. We studied thirteen Asian patients with pulmonary nontuberculous mycobacterial disease treated with clofazimine at the NHO Kinki Chuo Chest Medical Center. In three patients (two women and one man) whose dosing regimens were altered owing to skin discoloration, we continuously measured luminance (L*), red-green (a*), and yellow-blue (b*) values (using a colorimeter) in both sun-exposed and sun-unexposed skin areas at each visit. Compared to baseline L* and a* values, the ΔL* values were negative (decreased brightness) and Δa* values were positive (increased redness) while patients received daily clofazimine. After switching to intermittent or reduced dosing, these changes gradually diminished. If such a dose reduction does not affect the therapeutic outcome, an even lower clofazimine dose may be attempted to minimize skin adverse effects.

3.
J Infect Chemother ; 30(8): 780-784, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38182008

ABSTRACT

Patients with Mycobacterium avium complex pulmonary disease (MAC-PD) often suffer from chronic symptoms such as sputum production, which reduces quality of life. Oscillatory positive expiratory pressure (OPEP) devices are used in physiotherapy to promote the clearance of respiratory secretions. We report two cases of improved lung function and improved scores on the Leicester Cough Questionnaire (LCQ) and the Breathlessness, Cough and Sputum Scale (BCSS) after the use of OPEP in patients with MAC-PD where treatment with guideline-based therapy, including amikacin liposome inhalation suspension, had proved ineffective for symptoms. Use of OPEP might maximize the efficacy of therapy and thereby improves outcomes in patients with MAC-PD. It is important to use both guideline-based therapy and OPEP, especially in patients whose health-related quality of life is affected by sputum symptoms. Further prospective studies are warranted to assess the benefit of adding OPEP to guidelines concerning therapy for patients with MAC-PD and sputum symptoms.


Subject(s)
Mycobacterium avium Complex , Mycobacterium avium-intracellulare Infection , Quality of Life , Humans , Mycobacterium avium-intracellulare Infection/therapy , Mycobacterium avium-intracellulare Infection/microbiology , Male , Aged , Sputum/microbiology , Female , Positive-Pressure Respiration/instrumentation , Positive-Pressure Respiration/methods , Middle Aged , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Treatment Outcome , Lung Diseases/microbiology , Lung Diseases/therapy , Lung Diseases/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL